A multicenter, randomized study of the sirolimus-eluting Bx Velocity balloon expandable stent vs. intravascular brachytherapy in the treatment of patients with in-stent restenotic coronary artery lesions.

Trial Profile

A multicenter, randomized study of the sirolimus-eluting Bx Velocity balloon expandable stent vs. intravascular brachytherapy in the treatment of patients with in-stent restenotic coronary artery lesions.

Completed
Phase of Trial: Phase III

Latest Information Update: 18 Jan 2017

At a glance

  • Drugs Sirolimus (Primary)
  • Indications Coronary artery disease; Coronary artery restenosis; Myocardial ischaemia; Restenosis
  • Focus Therapeutic Use
  • Acronyms SISR
  • Sponsors Cordis Corporation
  • Most Recent Events

    • 13 Oct 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top